NovaSeq 6000 Sequencing System is designed to adapt to your needs so groundbreaking discoveries are always within reach. It's flexible, scalable science on your terms. NovaSeq 6000 offers deeper ...

Illumina's NovaSeq 6000 stands as the latest breakthrough in ultra-high throughput NGS sequencing instrumentation. This dual flow cell instrument is meticulously designed to function with four ...

The NovaSeq X and NovaSeq X Plus systems were purpose-designed to be our most sustainable sequencing systems with reductions in packaging weight and waste, maximizing storage space and saving on ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow ...

CEO Jacob Thaysen highlighted the transformative progress Illumina ... Sequencing consumables revenue reached $698 million, reflecting 2% year-over-year growth, driven by increased utilization of ...

whole-transcriptome sequencing, and epigenetic analysis. The NovaSeq X Plus instrument is now available and ready for submissions! The 2-channel chemistry, patterned flow-cells are best for large ...

potentially establishing themselves as long-term rivals to Illumina both within China and in other international markets. The NovaSeq X platform represents a significant advancement in sequencing ...

The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...

and Illumina expects its new NovaSeq X Series to enable the $100 genome, which could greatly increase the accessibility of genomic sequencing. At a lower cost, genomic sequencing could even have ...

it took Illumina five years to develop its latest sequencing platform, the NovaSeq X, which we use as a barometer for how long it could take for a competitor to engineer a similar product.

As the cost of sequencing continues to decrease, more researchers and clinicians may be able to incorporate genomic analysis into their work, expanding the overall market for Illumina’s products. The ...